search
Back to results

Evaluation of Non-opioid Balanced General Anesthesia in Cardiac Surgery With Extracorporeal Circulation: a Randomized, Controlled, Multicenter Superiority Trial (OFACAR)

Primary Purpose

Opioid-free Anesthesia, Cardiac Surgery

Status
Recruiting
Phase
Phase 3
Locations
France
Study Type
Interventional
Intervention
Balanced general anesthesia without morphine
Standard general anesthesia balanced with morphine
Data collection
Assessment of pain
Recovery quality score
Sponsored by
Centre Hospitalier Universitaire Dijon
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Opioid-free Anesthesia

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patient who has provided written and informed consent
  • Adult patient
  • Patient undergoing cardiac surgery which is:

    1. Scheduled
    2. With bypass surgery
    3. Of the following types: aortic valve surgery, mitral valve surgery, tricuspid valve surgery, atrial myxoma, coronary artery bypass surgery, aortic surgery, combined surgery

Exclusion Criteria:

  • Person not affiliated to national health insurance
  • Person under legal protection (curatorship, guardianship)
  • Person under court order
  • Pregnant or breastfeeding woman
  • Adult unable to express consent
  • Patient already included once in the study
  • Patient requiring emergency surgery within 24 hours
  • Patients with hypersensitivity to local anesthetics or opiates or to any of the excipients in the products used
  • Patients on antidepressants, neuroleptics such as non-selective MAOIs (iproniazid), selective A MAOI (moclobemide), selective B MAOI (selegiline) gabapentin (Neurontin®)
  • Patients with an unprotected atrioventricular conduction disorder
  • Patients with a prolonged QTc (> 450 ms) on preoperative ECG
  • Patient with severe liver failure (PT< 30%)
  • Patient suffering from respiratory failure (Long-term oxygen therapy patient except OSA)
  • Patient with uncontrolled epilepsy
  • Patient with preoperative cognitive dysfunction (MMS <24)
  • Patient with intracranial hypertension
  • Patient with chronic kidney failure (dialysis, creatinine > 200 μmol L-1)
  • Patient with porphyria
  • Patients treated with linezolid (Zyvoxid®)
  • Patients with severe arterial hypotension (systolic BP<90 mmHg)

Sites / Locations

  • Chu Dijon BourgogneRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Intervention

Controle

Arm Description

Outcomes

Primary Outcome Measures

Occurrence of at least one postoperative complication
Post-operative complications: postoperative neurological dysfunction acute renal failure acute respiratory failure cardiovascular complications death

Secondary Outcome Measures

Full Information

First Posted
May 10, 2021
Last Updated
November 24, 2021
Sponsor
Centre Hospitalier Universitaire Dijon
search

1. Study Identification

Unique Protocol Identification Number
NCT04886453
Brief Title
Evaluation of Non-opioid Balanced General Anesthesia in Cardiac Surgery With Extracorporeal Circulation: a Randomized, Controlled, Multicenter Superiority Trial
Acronym
OFACAR
Official Title
Evaluation of Non-opioid Balanced General Anesthesia in Cardiac Surgery With Extracorporeal Circulation: a Randomized, Controlled, Multicenter Superiority Trial
Study Type
Interventional

2. Study Status

Record Verification Date
November 2021
Overall Recruitment Status
Recruiting
Study Start Date
August 30, 2021 (Actual)
Primary Completion Date
May 2024 (Anticipated)
Study Completion Date
May 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier Universitaire Dijon

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Opioid-free anesthesia (OFA) is a general anesthesia based on the use of hypnotics and non-opioid analgesics (lidocaine, ketamine, dexamethasone, esmolol). This technique has been used for the past 10 years, during which randomized and non-randomized studies have demonstrated a number of positive effects on cardiac function: better analgesia and decreased postoperative morphine consumption, better respiratory function, better hemodynamic stability, better postoperative cognitive function. The hypothesis of the present study is that the use of OFA during cardiac surgery is associated with: Improved intraoperative hemodynamic stability A decrease in the incidence of postoperative complications A reduction in intensive care and hospital length of stay

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Opioid-free Anesthesia, Cardiac Surgery

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
320 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention
Arm Type
Experimental
Arm Title
Controle
Arm Type
Active Comparator
Intervention Type
Drug
Intervention Name(s)
Balanced general anesthesia without morphine
Intervention Description
Balanced general anesthesia without morphine
Intervention Type
Drug
Intervention Name(s)
Standard general anesthesia balanced with morphine
Intervention Description
Standard general anesthesia balanced with morphine
Intervention Type
Other
Intervention Name(s)
Data collection
Intervention Description
Data collection
Intervention Type
Other
Intervention Name(s)
Assessment of pain
Intervention Description
visual analog scale
Intervention Type
Other
Intervention Name(s)
Recovery quality score
Intervention Description
QoR15 questionnaire
Primary Outcome Measure Information:
Title
Occurrence of at least one postoperative complication
Description
Post-operative complications: postoperative neurological dysfunction acute renal failure acute respiratory failure cardiovascular complications death
Time Frame
30 days post-surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient who has provided written and informed consent Adult patient Patient undergoing cardiac surgery which is: Scheduled With bypass surgery Of the following types: aortic valve surgery, mitral valve surgery, tricuspid valve surgery, atrial myxoma, coronary artery bypass surgery, aortic surgery, combined surgery Exclusion Criteria: Person not affiliated to national health insurance Person under legal protection (curatorship, guardianship) Person under court order Pregnant or breastfeeding woman Adult unable to express consent Patient already included once in the study Patient requiring emergency surgery within 24 hours Patients with hypersensitivity to local anesthetics or opiates or to any of the excipients in the products used Patients on antidepressants, neuroleptics such as non-selective MAOIs (iproniazid), selective A MAOI (moclobemide), selective B MAOI (selegiline) gabapentin (Neurontin®) Patients with an unprotected atrioventricular conduction disorder Patients with a prolonged QTc (> 450 ms) on preoperative ECG Patient with severe liver failure (PT< 30%) Patient suffering from respiratory failure (Long-term oxygen therapy patient except OSA) Patient with uncontrolled epilepsy Patient with preoperative cognitive dysfunction (MMS <24) Patient with intracranial hypertension Patient with chronic kidney failure (dialysis, creatinine > 200 μmol L-1) Patient with porphyria Patients treated with linezolid (Zyvoxid®) Patients with severe arterial hypotension (systolic BP<90 mmHg)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Belaid BOUHEMAD
Phone
03.80.29.35.28
Email
belaid.bouhemad@chu-dijon.fr
Facility Information:
Facility Name
Chu Dijon Bourgogne
City
Dijon
ZIP/Postal Code
21000
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Belaid BOUHEMAD
Phone
03.80.29.35.28
Email
belaid.bouhemad@chu-dijon.fr

12. IPD Sharing Statement

Learn more about this trial

Evaluation of Non-opioid Balanced General Anesthesia in Cardiac Surgery With Extracorporeal Circulation: a Randomized, Controlled, Multicenter Superiority Trial

We'll reach out to this number within 24 hrs